279 related articles for article (PubMed ID: 8912803)
1. A community survey of adverse effects of cannabis use.
Thomas H
Drug Alcohol Depend; 1996 Nov; 42(3):201-7. PubMed ID: 8912803
[TBL] [Abstract][Full Text] [Related]
2. Cannabis and the brain.
Castle DJ; Ames FR
Aust N Z J Psychiatry; 1996 Apr; 30(2):179-83. PubMed ID: 8811260
[TBL] [Abstract][Full Text] [Related]
3. Cannabis use in a large sample of acute psychiatric admissions.
Mathers DC; Ghodse AH; Caan AW; Scott SA
Br J Addict; 1991 Jun; 86(6):779-84. PubMed ID: 1878628
[TBL] [Abstract][Full Text] [Related]
4. Psychiatric comorbidity associated with synthetic cannabinoid use compared to cannabis.
Bassir Nia A; Medrano B; Perkel C; Galynker I; Hurd YL
J Psychopharmacol; 2016 Dec; 30(12):1321-1330. PubMed ID: 27462088
[TBL] [Abstract][Full Text] [Related]
5. Cannabis policy: time to move beyond the psychosis debate.
Werb D; Fischer B; Wood E
Int J Drug Policy; 2010 Jul; 21(4):261-4. PubMed ID: 20381329
[No Abstract] [Full Text] [Related]
6. Psychopathologic differences between cannabis-induced psychoses and recent-onset primary psychoses with abuse of cannabis.
Rubio G; Marín-Lozano J; Ferre F; Martínez-Gras I; Rodriguez-Jimenez R; Sanz J; Jimenez-Arriero MA; Carrasco JL; Lora D; Jurado R; López-Trabada JR; Palomo T
Compr Psychiatry; 2012 Nov; 53(8):1063-70. PubMed ID: 22682680
[TBL] [Abstract][Full Text] [Related]
7. Cannabis use at a young age is associated with psychotic experiences.
Schubart CD; van Gastel WA; Breetvelt EJ; Beetz SL; Ophoff RA; Sommer IE; Kahn RS; Boks MP
Psychol Med; 2011 Jun; 41(6):1301-10. PubMed ID: 20925969
[TBL] [Abstract][Full Text] [Related]
8. [Sociodemographic profiles, addictive and mental comorbidity in cannabis users in an outpatient specific setting].
Guillem E; Pelissolo A; Vorspan F; Bouchez-Arbabzadeh S; Lépine JP
Encephale; 2009 Jun; 35(3):226-33. PubMed ID: 19540408
[TBL] [Abstract][Full Text] [Related]
9. Do police arrestees substitute legal highs for other drugs?
Wilkins C; Parker K; Prasad J; Jawalkar S
Int J Drug Policy; 2016 May; 31():74-9. PubMed ID: 26948501
[TBL] [Abstract][Full Text] [Related]
10. Psychosocial sequelae of cannabis use and implications for policy: findings from the Christchurch Health and Development Study.
Fergusson DM; Boden JM; Horwood LJ
Soc Psychiatry Psychiatr Epidemiol; 2015 Sep; 50(9):1317-26. PubMed ID: 26006253
[TBL] [Abstract][Full Text] [Related]
11. Differential effects of sex on substance use between first episode psychosis patients and healthy people.
Núñez C; Ochoa S; Huerta-Ramos E; Baños I; Barajas A; Dolz M; Sánchez B; Del Cacho N; ; Usall J
Compr Psychiatry; 2016 Aug; 69():169-78. PubMed ID: 27423358
[TBL] [Abstract][Full Text] [Related]
12. Cannabis use and dependence in a New Zealand birth cohort.
Fergusson DM; Horwood LJ
N Z Med J; 2000 May; 113(1109):156-8. PubMed ID: 10894340
[TBL] [Abstract][Full Text] [Related]
13. Emerging patterns of cannabis and other substance use in Aboriginal communities in Arnhem Land, Northern Territory: a study of two communities.
Clough AR; D'Abbs P; Cairney S; Gray D; Maruff P; Parker R; O'Reilly B
Drug Alcohol Rev; 2004 Dec; 23(4):381-90. PubMed ID: 15763742
[TBL] [Abstract][Full Text] [Related]
14. [Schizophrenia and cannabis consumption: epidemiology and clinical symptoms].
Jockers-Scherübl MC
Prax Kinderpsychol Kinderpsychiatr; 2006; 55(7):533-43. PubMed ID: 17058779
[TBL] [Abstract][Full Text] [Related]
15. Psychiatric aspects of cannabis use in adolescents and young adults.
Tunving K
Pediatrician; 1987; 14(1-2):83-91. PubMed ID: 3497393
[TBL] [Abstract][Full Text] [Related]
16. Cannabis use in psychotic patients.
Sembhi S; Lee JW
Aust N Z J Psychiatry; 1999 Aug; 33(4):529-32. PubMed ID: 10483847
[TBL] [Abstract][Full Text] [Related]
17. The effect of marijuana use on the risk for schizophrenia.
Evins AE; Green AI; Kane JM; Murray RM
J Clin Psychiatry; 2012 Nov; 73(11):1463-8. PubMed ID: 23218162
[No Abstract] [Full Text] [Related]
18. Cannabis use and psychiatric and cogitive disorders: the chicken or the egg?
Di Forti M; Morrison PD; Butt A; Murray RM
Curr Opin Psychiatry; 2007 May; 20(3):228-34. PubMed ID: 17415074
[TBL] [Abstract][Full Text] [Related]
19. [For and against: cannabis].
Schaub M; Dürsteler-MacFarland K; Stohler R; Thomasius R
Psychiatr Prax; 2005 Mar; 32(2):58-61. PubMed ID: 15712036
[No Abstract] [Full Text] [Related]
20. A systematic review of adverse events arising from the use of synthetic cannabinoids and their associated treatment.
Tait RJ; Caldicott D; Mountain D; Hill SL; Lenton S
Clin Toxicol (Phila); 2016; 54(1):1-13. PubMed ID: 26567470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
